Advertisement
Canada markets closed

  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     

  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • CAD/USD

    0.7284
    +0.0023 (+0.32%)
     

  • CRUDE OIL

    79.06
    +0.06 (+0.08%)
     

  • Bitcoin CAD

    79,621.09
    -3,655.30 (-4.39%)
     

  • CMC Crypto 200

    1,271.66
    -67.40 (-5.04%)
     

  • GOLD FUTURES

    2,331.10
    +20.10 (+0.87%)
     

  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     

  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     

  • NASDAQ futures

    17,503.25
    +65.00 (+0.37%)
     

  • VOLATILITY

    15.39
    -0.26 (-1.66%)
     

  • FTSE

    8,121.24
    -22.89 (-0.28%)
     

  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     

  • CAD/EUR

    0.6793
    -0.0009 (-0.13%)
     

Maternus-Kliniken Full Year 2022 Earnings: €0.67 loss per share (vs €0.12 loss in FY 2021)

Simply Wall St
·1 min read

Maternus-Kliniken (ETR:MAK) Full Year 2022 Results

Key Financial Results

  • Revenue: €114.3m (up 2.6% from FY 2021).

  • Net loss: €14.1m (loss widened by 467% from FY 2021).

  • €0.67 loss per share (further deteriorated from €0.12 loss in FY 2021).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Maternus-Kliniken shares are down 17% from a week ago.

Risk Analysis

Be aware that Maternus-Kliniken is showing 3 warning signs in our investment analysis and 2 of those are potentially serious...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here